Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wiltrom has developed and commercialized several high-end implantable Class II/III medical devices for spine surgery. Its flagship product "Tripod-Fix" minimally invasive spinal fixation system has received TFDA approval in Taiwan and MDD approval in Europe. Over 1,400 real-world cases have been accumulated as of 2023. The company continues to expand into the EU and US markets with ongoing post-market studies and FDA submission preparations
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wiltrom.